[1] Villanueva A. Hepatocellular Carcinoma. New Engl J Med, 2019, 380: 1450-1462.
[2] Lee S, Schmitt CA. The dynamic nature of senescence in cancer. Nat Cell Biol, 2019, 21: 94-101.
[3] Frey N, Venturelli S, Zender L, et al. Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics. Nat Rev Gastroenterol Hepatol, 2018, 15: 81-95.
[4] Coppé J P, Patil CK, Rodier F, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol, 2008, 6: 2853-2868.
[5] Li F, Huangyang P, Burrows M, et al. FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome. Nat Cell Biol, 2020, 22: 728-739.
[6] Wakita M, Takahashi A, Sano O, et al. A BET family protein degrader provokes senolysis by targeting NHEJ and autophagy in senescent cells. Nat Commun, 2020, 11: 1935.
[7] Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev, 2008, 88: 125-172.
[8] Yoshimoto S, Loo T M, Atarashi K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature, 2013, 499: 97-101.
[9] Eggert T, Wolter K, Ji J, et al. Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression. Cancer cell, 2016, 30: 533-547.
[10] Liu F, Li X, Lu C, et al. Ceramide activates lysosomal cathepsin B and cathepsin D to attenuate autophagy and induces ER stress to suppress myeloid-derived suppressor cells. Oncotarget, 2016, 7: 83907-83925.
[11] Tian Z, Chen Y, Gao B. Natural killer cells in liver disease. Hepatology (Baltimore, Md), 2013, 57: 1654-62.
[12] De Oliveira Da Silva B, Ramos L F, Moraes K C M. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis.Cell Biol Int, 2017, 41: 946-959.
[13] Childs B G, Gluscevic M, Baker D J, et al. Senescent cells: an emerging target for diseases of ageing. Nature Rev Drug Discov, 2017, 16: 7187-35.
[14] Demaria M, O'leary M N, Chang J, et al. Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse. Cancer Discov, 2017, 7: 165-176.
[15] Wang C, Vegna S, Jin H, et al. Inducing and exploiting vulnerabilities for the treatment of liver cancer. Nature, 2019, 574: 268-272. |
